| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6200452 | Ophthalmology | 2016 | 8 Pages |
Abstract
At both 1 and 2 years after initiation of anti-VEGF treatment in CATT, eyes with RAP were less likely to have fluid, FA leakage, scar, and SHRM and more likely to have GA than eyes without RAP. Mean improvement in VA was similar at 2 years.
Keywords
CNVSHRMNVAMDCATTRPERAPChoroidal neovascularizationgeographic atrophyfluorescein angiographyretinal pigment epitheliumOctOptical coherence tomographyretinal angiomatous proliferationVisual acuityneovascular age-related macular degenerationVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)Comparison of Age-Related Macular Degeneration Treatments Trialsdisc areasubretinal hyperreflective material
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Ebenezer MPH, PhD, James MS, Gui-shuang PhD, Juan E. MD, Daniel F. MD, Glenn J. MD, Maureen G. PhD,